Unbiased Analysis of Today's Healthcare Issues
For patients with serious illnesses, timeline access to efficacious medications is paramount. The European Medicines Agency (EMA) was created in part to help expedite drug approvals and insure these products are save and effective. As stated in a paper by Grünwald and Stargardt (2024): The EMA [European Medicines Agency] was founded in 1995 primarily to…
How did health care prices change over the past 2 decades. That is the question a paper by Papanicolas (2024) aims to answer, comparing US prices to those from Australia, Canada, France, and the Netherlands between 2000 and 2020. Before we get to the results, we first need to determine what types of price indices…
Perhaps so according to the health policy editor at the Guardian. He writes that as NHS has grown weaker, private medical insurance is becoming a more attractive option. The long delays for NHS care that are now endemic – and cause so much worry, risk and harm to those left waiting – are not going…
Initially yes, but not after this initial penalty. That is the finding from a paper by Kettlewell and Zhang (2024) using an analysis of the Australian health care system. Financial penalties for delayed enrollment could be useful tools to encourage people to enroll earlier in health insurance markets, but little is known about how effective…
A great paper by Gruber et al. 2023 looks at the evolution of long-term care for ten countries: Canada, Denmark, England, Germany, Italy, Japan, the Netherlands, Singapore, Spain and the United States. Long-term care is divided into three categories: institutional care, formal home care, and informal care. For the 10 countries examined, the paper finds…
In countries that have universal health insurance, but limited patient out-of-pocket costs for public hospital services, non-urgent hospital treatment often has a waiting list in public hospitals. To address this issue, some countries (e.g., UK, Canada) use strategies such as setting maximum wait targets, monitoring provider performance, or adding public funding; other countries (e.g., Australia,…
That is the title of a paper by Bodnar et al. 2023. A summary of this interesting paper is below. Overview of general practitioners in the UK Under the English National Health Service (NHS) program, …patients register with a single general practice that acts as the gatekeeper to most other NHS services, including non-emergency hospital…
Last week, FDA authorized the State of Florida to import pharmaceuticals from Canada. The price of branded pharmaceuticals in the US is nearly three times the cost of identical pharmaceuticals in Canada, so this approach could save the US money. While there are some administrative issues to work out on the US side, the biggest…
According to the OECD, In 2021 the U.S. spent $1,432/capita on pharmaceuticals compared to only $517/per capita in the UK. The UK’s figure was slightly higher that Poland and Norway, but less than Latvia, the Slovak Republic, Portugal and Romania. How does the UK spend so little on drugs? Many people focus on the efforts…
As individuals live longer, governments and employers are considering increasing the age at which individuals become eligible for either public or private pensions (e.g., Social Security). Why this fiscal impacts of changing the retirement age has been well-studied, the labor market and health outcomes are less well-known. A paper by Serrano-Alarcón et al. (2023) examines…